Drugs / Vantris
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02271035 Comparator | Oct 2014 → Oct 2015 | vesicoureteral reflux | Rabin Medical Center | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vantris | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02271035 ↗ |
| Route | Other | “vantris will be injected through the working channel of the cystoscope using a special needle into the submucosal space of the ureteral orifice” NCT02271035 ↗ |